Akeega

Imported from official source

Akeega Active substance Niraparib and abiraterone acetate Holder Janssen-Cilag NV Status Running Indication with prednisone or prednisolone and in combination with androgen deprivation therapy (ADT) for the treatment of adult patients with metastatic hormone-sensitive prostate cancer (mHSPC) and BRCA 1/2 mutations, (germline and/or somatic) Public documents Approbation   Information for the …

This version

Version
1 of 1
Recorded
October 21, 2026 06:32
Change
Initial
Content hash
b210bc9a5368a8e55b67b1c6a20b7174
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.